RIVU RIVULET MEDIA INC.

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Picture this: you're at the wheel of a beastly 18-wheeler, barreling down the highway and skipping weigh stations thanks to PrePass. But here’s where the real magic kicks in. PrePass Intelligence just rolled out, aiming to squeeze every last drop of value from bypass and toll data. That's cold hard cash for fleet operators who can finally make sense of these fleeting...

Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Saluting a Veteran's Advocate Amidst a world obsessed with bottom lines and market swings, it’s refreshing to spotlight someone like Sarah R. Weede. She's not about the Wall Street grind but you better believe her drive and dedication rival any big-shot CEO. Leadership in Veterans Services Sarah Weede's story starts with substantial roots planted in serving those who...

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Promising Results for APG777 at EADV Congress 2025 Apogee Therapeutics, Inc., a forward-thinking biotechnology company dedicated to developing groundbreaking treatments, has generated excitement with its recent announcement regarding APG777. This innovative therapeutic is being highlighted at the upcoming EADV Congress 2025. The preliminary data from the Phase 2 APEX...

Class Action Lawsuit Notification for Marqeta Investors Levi & Korsinsky, LLP informs investors of Marqeta, Inc. about an important class action lawsuit. This legal action aims to support those who feel they’ve been adversely impacted by alleged securities fraud during a specific time period. Understanding the Class Definition This lawsuit is established for the benefit...

Understanding Recent Trends in Walt Disney Options Investors are increasingly showing confidence in Walt Disney as they engage in options trading. The latest analysis reveals a robust bullish sentiment among traders, indicating optimism for the company's future performance. Exploring DIS Options Activity Recent reports highlight a noticeable uptick in options activity for...

Investigation into StubHub Holdings, Inc. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating potential claims regarding StubHub Holdings, Inc. (NYSE: STUB). This inquiry aims to provide a route for investors who believe they may have experienced losses due to misrepresentation or failure to disclose critical information by the...

Gulf & Pacific Equities Corp. Reports on Second Quarter Results In a recent update, Gulf & Pacific Equities Corp. (TSX-V: GUF), an established leader in the acquisition, management, and development of anchored shopping centers across Western Canada, has announced its second quarter financial results. The company reported a modest decline in revenues of 1.7%, totaling...